- Aerie Pharmaceuticals Inc. (AERI) is down -58.96% this year
- Qutoutiao Inc. (QTT) Stock Price Stood at $2.47 on Monday, October 19, What You Think?
- MINISO Group Holding Limited (MNSO) Closed at $20.88 on Monday
- Riot Blockchain Inc. (RIOT) Surged 6.11%, Can Traders Take Benefit?
- XPeng Inc. (XPEV): Important & Key Factors of Consumer Cyclical Stock
Jefferies announced it was Downgrade coverage of China Biologic Products Holdings Inc. in a research note on March 11, 2019. The analysts assigned an Underperform rating to the stock with a price target of $62. Morgan Stanley rated the stock as a Equal-weight in a research noted published on November 05, 2018. Credit Suisse rated the stock as a Neutral in a research note published on August 06, 2018.
CBPO Recent Trade
The share price of CBPO descended by -$0.2 during the exchanging session on 07/20/20 to exchange at $107.23. China Biologic Products Holdings Inc. stock has an exchanging volume of 0.13 million shares, which is high, contrasted with its 3-months average volume of 103.72K shares. Its market capitalization has now reached to $4.14B and analysts have a consensus target price of $96.22 in the 12-month period.
CBPO Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, CBPO price has rose by 0.64%. In the course of past three months sees the stock go down around -1.17%, while it has lost -7.40% over the past six months and -7.86% since the start of the year.
CBPO Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), China Biologic Products Holdings Inc. posted $1.56 earnings per share (EPS) which was above the consensus estimate of $1.38 by $0.18, which represents to an expansion by 13.00%.
CBPO Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on China Biologic Products Holdings Inc. has seen its stock exchanging -3.90% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +7.51% above its three-month low. A more extensive look sees CBPO exchanging -10.22% beneath its 52-week high and 16.28% above from its 52-week low price.
CBPO Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 1.45%, while it has a month to month instability of 2.28%. The company has an ATR (Average True Range) of 2.19 and a beta factor of 0.82.